Market Tracker

02/21 4:28pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.94
Delayed Data
As of 4:00pm ET
 +0.47 / +31.97%
Today’s Change
0.49
Today|||52-Week Range
3.05
+98.00%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.47
Today’s open1.54
Day’s range1.47 - 1.94
Volume1,847,553
Average volume (3 months)378,159
Market cap$43.2M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+7.95%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.05+2.00%
TRILTrillium Therapeutic...-0.15-2.24%
INISInternational Isotop...-0.01-8.00%
BMRABiomerica Inc-0.03-1.17%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts